Literature DB >> 20868310

Successful use of infliximab in macrophage activation syndrome with severe CNS involvement.

A Sellmer, B Stausbøl-Grøn, B Krag-Olsen, T Herlin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20868310     DOI： 10.3109/03009742.2010.508468

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN： 0300-9742            Impact factor:   3.641


× No keyword cloud information.
  6 in total

1.  [Macrophage activation syndrome].

Authors:  P Lehmann; E Huber; T Dörner; M Fleck
Journal:  Z Rheumatol       Date:  2012-10       Impact factor: 1.372

Review 2.  Not all hemophagocytes are created equally: appreciating the heterogeneity of the hemophagocytic syndromes.

Authors:  Scott W Canna; Edward M Behrens
Journal:  Curr Opin Rheumatol       Date:  2012-01       Impact factor: 5.006

Review 3.  The critical role of macrophages in the pathogenesis of hidradenitis suppurativa.

Authors:  Ahmed Shah; Raed Alhusayen; Saeid Amini-Nik
Journal:  Inflamm Res       Date:  2017-06-27       Impact factor: 4.575

4.  Mechanisms of action of ruxolitinib in murine models of hemophagocytic lymphohistiocytosis.

Authors:  Sabrin Albeituni; Katherine C Verbist; Paige E Tedrick; Heather Tillman; Jennifer Picarsic; Rachel Bassett; Kim E Nichols
Journal:  Blood       Date:  2019-04-23       Impact factor: 22.113

Review 5.  Epstein-Barr Virus and Hemophagocytic Lymphohistiocytosis.

Authors:  Rebecca A Marsh
Journal:  Front Immunol       Date:  2018-01-08       Impact factor: 7.561

Review 6.  Targeting TNF-α for COVID-19: Recent Advanced and Controversies.

Authors:  Yi Guo; Ke Hu; Yuxuan Li; Chanjun Lu; Ken Ling; Chuanqi Cai; Weici Wang; Dawei Ye
Journal:  Front Public Health       Date:  2022-02-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.